MARKET

OXBDF

OXBDF

Oxford Biomedica
OTCPK
11.30
NaN%
Closed 09:30 02/20 EST
OPEN
--
PREV CLOSE
11.30
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
12.35
52 WEEK LOW
3.150
MARKET CAP
1.37B
P/E (TTM)
-23.2990
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OXBDF last week (0209-0213)?
Weekly Report · 5d ago
Oxford Biomedica Wins More Time for EQT Takeover Decision
TipRanks · 02/11 15:07
Weekly Report: what happened at OXBDF last week (0202-0206)?
Weekly Report · 02/09 09:43
Bristol-Myers, OXB sign multi-year CAR-T supply deal
Seeking Alpha · 02/04 11:47
Oxford Biomedica seals multi-year CAR-T vector supply deal with Bristol Myers Squibb
TipRanks · 02/04 07:26
Weekly Report: what happened at OXBDF last week (0126-0130)?
Weekly Report · 02/02 09:43
Oxford Biomedica Confirms Total Voting Rights at 120.8 Million Shares
TipRanks · 02/02 08:27
Weekly Report: what happened at OXBDF last week (0119-0123)?
Weekly Report · 01/26 09:43
More
About OXBDF
Oxford Biomedica PLC is a contract development and manufacturing organization (CDMO) in cell and gene therapy. The Company is engaged in providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. It offers a number of technologies for viral vector manufacturing, including a fourth-generation lentiviral vector system (the TetraVecta system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines. Its LentiVector platform technology is an advanced lentiviral vector-based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. Its AAV platform, which offers a proprietary plug and play dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies.

Webull offers Oxford BioMedica plc stock information, including OTCPK: OXBDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OXBDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OXBDF stock methods without spending real money on the virtual paper trading platform.